About Snehal Pharma
Snehal Pharma is a Healthcare company. Pharmaceutical formulation manufacturing and distribution in Nagpur, India. The company has 38 employees. Its Indian entity Snehal Pharma & Surgicals Private Limited reported revenue of ₹20.74 Cr. Snehal Pharma offers products and services including Tablets and Capsules. Its focus areas include Pharmaceuticals, Distribution, Wholesale Supply and Drug Manufacturing.
Company details
Snehal Pharma is identified as a pharmaceutical formulation manufacturing organization based in Nagpur, India, with production facilities situated in the MIDC area of Butibori. Quality control and assurance processes are overseen by post-graduate professionals approved by the FDA Maharashtra, ensuring compliance with WHO GMP norms. Products such as tablets, capsules, liquids, and external preparations are developed and manufactured by experienced supervisors and operators. The premises are maintained in a clean environment, adhering to regulatory standards, while distribution activities are handled through authorized channels. This focus on innovation and quality is supported by leadership dedicated to therapeutic advancements.
- Employees 38
- SectorsHealthcare
- Email••••••••
- Legal Name Snehal Pharma & Surgicals Pvt. Ltd
- Date of Incorporation 06 Jun, 2011
- Jurisdiction Mumbai, Maharashtra, India
- Indian entity revenue₹20.74 Cr
FY 2024 · -25% YoY
- Indian entity net loss-₹4.63 Cr
FY 2024 · -22% margin
- Indian entity EBITDA₹2.53 Cr
FY 2024 · 12% margin
- Employee Count38
Associated legal entities of Snehal Pharma
Snehal Pharma operates through Snehal Pharma & Surgicals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Snehal Pharma & Surgicals Private Limited CIN U33110MH2011PTC218317 | Active | 06 Jun 2011 | Mumbai, Maharashtra | ₹20.7 Cr | 38 | 2 | View details |
Products & Services of Snehal Pharma
Snehal Pharma offers a comprehensive portfolio of products and services, including Tablets and Capsules.
Tablets are manufactured for therapeutic uses under supervision by qualified personnel in facilities approved by regulatory bodies.
Capsules are produced in compliance with quality assurance techniques and regulatory standards by experienced operators.
Board of directors of Snehal Pharma & Surgicals Private Limited (Snehal Pharma)
Snehal Pharma & Surgicals Private Limited is the primary company behind Snehal Pharma. The board of Snehal Pharma & Surgicals Private Limited currently have 2 directors; the longest-serving is Sudhir Ravindra Deulgaonkar, appointed in 2011. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sudhir Ravindra Deulgaonkar DIN 03539145 | Managing Director | 06 Jun 2011 | 15 yrs 4 mo | Snehal Pharma & Surgicals Private Limited |
| Subodh Ravindra Deulgaonkar DIN 03542441 | Director | 06 Jun 2011 | 15 yrs 4 mo | Snehal Pharma & Surgicals Private Limited |
Financials of Snehal Pharma
Figures of Snehal Pharma & Surgicals Private Limited, the primary company behind Snehal Pharma, for FY 2024. Revenue was ₹20.74 Cr (-25% year on year). Net loss was -₹4.63 Cr (-22% margin). EBITDA was ₹2.53 Cr (12% margin). Revenue has grown at a compounded annual rate of -1% over three years and +15% over five years.
- ₹20.74 CrRevenue · FY 2024 · -25% YoY
- -₹4.63 CrNet loss · -22% margin
- ₹2.53 CrEBITDA · 12% margin
- ₹7.29 CrPaid-up capital
- 38Employees (provident fund records)
- -1%Revenue CAGR, 3 years
- +15%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Snehal Pharma & Surgicals Private Limited are on its company page.
Detailed financial statements for Snehal Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Snehal Pharma
Snehal Pharma has 38 employees.
The primary company behind Snehal Pharma, Snehal Pharma & Surgicals Private Limited, reported revenue of ₹20.74 Cr for FY 2024, down 25% year on year.
Snehal Pharma is identified as a pharmaceutical formulation manufacturing organization based in Nagpur, India, with production facilities situated in the MIDC area of Butibori. Quality control and assurance processes are overseen by post-graduate professionals approved by the FDA Maharashtra, ensuring compliance with WHO GMP norms. Products such as tablets, capsules, liquids, and external preparations are developed and manufactured by experienced supervisors and operators. The premises are maintained in a clean environment, adhering to regulatory standards, while distribution activities are handled through authorized channels. This focus on innovation and quality is supported by leadership dedicated to therapeutic advancements.
Snehal Pharma offers Tablets and Capsules.
Snehal Pharma operates through Snehal Pharma & Surgicals Private Limited.
The legal entities of Snehal Pharma currently have 2 directors, including Sudhir Ravindra Deulgaonkar, Subodh Ravindra Deulgaonkar.